Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 586

    1.

    Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.

    Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P; Casale Monferrato Study.

    Diabetes Care. 2003 Jul;26(7):2150-5.PMID: 12832328 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

    Romero P, Salvat M, Fernández J, Baget M, Martinez I.

    J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.

    Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo-Perin P; Casale Monferrato Study.

    Diabetologia. 2005 Mar;48(3):427-34. Epub 2005 Feb 5.PMID: 15696295 [PubMed - indexed for MEDLINE]Related articles

    4.

    Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.

    Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ.

    Diabetes Care. 1993 Oct;16(10):1376-83.PMID: 8269796 [PubMed - indexed for MEDLINE]Related articles

    5.

    Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'.

    Esmatjes E, De Alvaro F; 'Estudio Diamante' Investigators.

    Diabetes Res Clin Pract. 2002 Jul;57(1):35-43.PMID: 12007728 [PubMed - indexed for MEDLINE]Related articles

    6.

    Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.

    Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N.

    Diabetologia. 2004 Jun;47(6):1020-8. Epub 2004 May 29.PMID: 15170497 [PubMed - indexed for MEDLINE]Related articles

    8.

    Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.

    Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.

    Diabetes Care. 1999 Jul;22(7):1176-80.PMID: 10388985 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Incipient and overt diabetic nephropathy in African Americans with NIDDM.

    Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skurnick JH.

    Diabetes Care. 1994 Apr;17(4):297-304.PMID: 8026285 [PubMed - indexed for MEDLINE]Related articles

    10.

    Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.

    Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU.

    Diabetes Care. 1998 Apr;21(4):530-4.PMID: 9571337 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The predictive value of microalbuminuria in IDDM. A five-year follow-up study.

    Almdal T, Nörgaard K, Feldt-Rasmussen B, Deckert T.

    Diabetes Care. 1994 Feb;17(2):120-5.PMID: 8137681 [PubMed - indexed for MEDLINE]Related articles

    12.

    Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

    Svensson M, Sundkvist G, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Henricsson M, Nyström L, Torffvit O, Waernbaum I, Ostman J, Eriksson JW; Diabetes Incidence Study in Sweden (DISS).

    Diabetes Care. 2003 Oct;26(10):2903-9.PMID: 14514599 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.

    Rossing P, Hougaard P, Parving HH.

    Diabetes Care. 2002 May;25(5):859-64.PMID: 11978681 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.

    Torffvit O, Agardh CD.

    J Diabetes Complications. 2001 Nov-Dec;15(6):307-13.PMID: 11711324 [PubMed - indexed for MEDLINE]Related articles

    15.
    16.

    Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.

    Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O.

    Nephrol Dial Transplant. 2004 Nov;19(11):2784-8. Epub 2004 Aug 24.PMID: 15328385 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.

    Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB; Danish Study Group of Diabetes in Childhood.

    J Diabetes Complications. 2004 May-Jun;18(3):160-4.PMID: 15145327 [PubMed - indexed for MEDLINE]Related articles

    18.

    Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway.

    Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G.

    Pediatr Diabetes. 2006 Oct;7(5):239-46.PMID: 17054444 [PubMed - indexed for MEDLINE]Related articles

    19.

    Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study.

    Bruno G, Biggeri A, Merletti F, Bargero G, Ferrero S, Pagano G, Perin PC.

    Diabetes Care. 2003 Aug;26(8):2353-8.PMID: 12882861 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data